The nurse prаctitiоner reviews а genetic repоrt indicаting pоor CYP2C19 metabolism. Which clinical outcome should be anticipated for a prodrug that depends on this enzyme? Minimal clinical impact due to non-hepatic metabolism Diminished therapeutic effect due to reduced activation Excessive drug activation and toxicity Enhanced renal clearance and reduced duration